Imidazole as a Promising Medicinal Scaffold: Current Status and Future Direction

References

• ShererC, SnapeTJ. Heterocyclic scaffolds as promising anticancer agents against tumours of the central nervous system: exploring the scope of indole and carbazole derivatives. Eur J Med Chem. 2015;97:552–560. doi:10.1016/j.ejmech.2014.11.00725466446
   PubMed Web of Science ®Google Scholar
• MolinaP, TárragaA, OtónF. Imidazole derivatives: a comprehensive survey of their recognition properties. Org Biomol Chem. 2012;10(9):1711–1724. doi:10.1039/c2ob06808g22281703
   PubMed Web of Science ®Google Scholar
• GabaM, MohanC. Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions. Med Chem Res. 2016;25(2):173–210.
   Web of Science ®Google Scholar
• Institute NC. Cancer statistics; 2020. Available from: https://www.cancer.gov/about-cancer/understanding/statistics. Accessed 720, 2021.
   Google Scholar
• UK CR. Worldwide cancer statistics; 2018. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer#heading-One. Accessed 720, 2021.
   Google Scholar
• Institute NC. What is cancer?; 2015. Available from: https://www.cancer.gov/about-cancer/understanding/what-is-cancer. Accessed 720, 2021.
   Google Scholar
• Pérez-HerreroE, Fernández-MedardeA. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur J Pharm Biopharm. 2015;93:52–79.25813885
   PubMed Web of Science ®Google Scholar
• AliR, MirzaZ, AshrafGM, et al. New anticancer agents: recent developments in tumor therapy. Anticancer Res. 2012;32(7):2999–3005.22753764
   PubMed Web of Science ®Google Scholar
• BaviskarAT, MadaanC, PreetR, et al. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase iiα and induce apoptosis in G1/S phase. J Med Chem. 2011;54(14):5013–5030. doi:10.1021/jm200235u21644529
   PubMed Web of Science ®Google Scholar
• ZhaoF, LuW, SuF, et al. Synthesis and potential antineoplastic activity of dehydroabietylamine imidazole derivatives. MedChemComm. 2018;9(12):2091–2099. doi:10.1039/C8MD00487K30746067
   PubMed Web of Science ®Google Scholar
• ChenJ, WangZ, LuY, DaltonJT, MillerDD, LiW. Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma. Bioorg Med Chem Lett. 2008;18(11):3183–3187. doi:10.1016/j.bmcl.2008.04.07318477505
   PubMed Web of Science ®Google Scholar
• DaoP, SmithN, Tomkiewicz-RauletC, et al. Design, synthesis, and evaluation of novel imidazo[1,2-a][1,3,5]triazines and their derivatives as focal adhesion kinase inhibitors with antitumor activity. J Med Chem. 2015;58(1):237–251. doi:10.1021/jm500784e25180654
   PubMed Web of Science ®Google Scholar
• SarkarzadehH, MiriR, FiruziO, et al. Synthesis and antiproliferative activity evaluation of imidazole-based indeno[1,2-b]quinoline-9,11-dione derivatives. Arch Pharm Res. 2013;36(4):436–447. doi:10.1007/s12272-013-0032-723440577
   PubMed Web of Science ®Google Scholar
• RoopashreeR, MohanCD, SwaroopTR, JagadishS, RangappaKS. Synthesis, characterization and in vivo biological evaluation of novel benzimidazoles as potential anticancer agents. Asian J Pharm Clin Res. 2014;7(5):309–313.
   Google Scholar
• AlkahtaniHM, AbbasAY, WangS. Synthesis and biological evaluation of benzo[d]imidazole derivatives as potential anti-cancer agents. Bioorg Med Chem Lett. 2012;22(3):1317–1321. doi:10.1016/j.bmcl.2011.12.08822225635
   PubMed Web of Science ®Google Scholar
• ChungK-H, HongS-Y, YouH-J, ParkR-E, RyuC-K. Synthesis and biological evaluation of 5-arylamino-1H-benzo[d]imidazole-4,7-diones as inhibitor of endothelial cell proliferation. Bioorg Med Chem. 2006;14(17):5795–5801. doi:10.1016/j.bmc.2006.05.05916784869
   PubMed Web of Science ®Google Scholar
• XueN, YangX, WuR, et al. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents. Bioorg Med Chem. 2008;16(5):2550–2557. doi:10.1016/j.bmc.2007.11.04818226907
   PubMed Web of Science ®Google Scholar
• MeenakshisundaramS, ManickamM, PillaiyarT. Exploration of imidazole and imidazopyridine dimers as anticancer agents: design, synthesis, and structure-activity relationship study. Arch Pharm (Weinheim). 2019;352(12):e1900011. doi:10.1002/ardp.20190001131596021
   PubMed Web of Science ®Google Scholar
• WuQ, SongY, LiuR, et al. Synthesis, docking studies and antitumor activity of phenanthroimidazole derivatives as promising c-myc G-quadruplex DNA stabilizers. Bioorg Chem. 2020;102:104074.32738566
   PubMed Web of Science ®Google Scholar
• FanC, ZhongT, YangH, et al. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo [d] imidazole-6-yl) quinazolin-4 (3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition. Eur J Med Chem. 2020;190:112108.32058239
   PubMed Web of Science ®Google Scholar
• KomuraiahB, RenY, XueM, et al. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities. Chem Biol Drug Des. 2021;97(5):1109–1116.33638903
   PubMed Web of Science ®Google Scholar
• HassanAY, El-SebaeySA, El DeebMA, ElzoghbiMS. Potential antiviral and anticancer effect of imidazoles and bridgehead imidazoles generated by HPV-Induced cervical carcinomas via reactivating the P53/pRb pathway and inhibition of CA IX. J Mol Struct. 2021;1230:129865.
   Web of Science ®Google Scholar
• AliEM, Abdel-MaksoudMS, AmmarUM, et al. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600E inhibitors. Bioorg Chem. 2021;106:104508.33280830
   PubMed Web of Science ®Google Scholar
• Al-BlewiF, ShaikhSA, NaqviA, et al. Design and synthesis of novel imidazole derivatives possessing triazole pharmacophore with potent anticancer activity, and in silico ADMET with GSK-3β molecular docking investigations. Int J Mol Sci. 2021;22(3):1162.33503871
   PubMed Web of Science ®Google Scholar
• ZhangM, DingY, QinH-X, et al. One-pot synthesis of substituted pyrrole–imidazole derivatives with anticancer activity. Mol Divers. 2020;24:1177–1184.31494841
   PubMed Web of Science ®Google Scholar
• BadieeP, HashemizadehZ. Opportunistic invasive fungal infections: diagnosis & clinical management. Indian J Med Res. 2014;139(2):195–204.24718393
   PubMed Web of Science ®Google Scholar
• US NIoH. Understanding emerging and re-emerging infectious diseases; 2007. Available from: https://www.ncbi.nlm.nih.gov/books/NBK20370/. Accessed 720, 2021.
   Google Scholar
• World Health Organization. Record number of countries contribute data revealing disturbing rates of antimicrobial resistance; 2020. Available from: https://www.who.int/news/item/01-06-2020-record-number-of-countries-contribute-data-revealing-disturbing-rates-of-antimicrobial-resistance.
   Google Scholar
• World Health Organization. Antimicrobial Resistance and Primary Health Care. World Health Organization; 2018.
   Google Scholar
• AnsariKF, LalC. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives. Eur J Med Chem. 2009;44(10):4028–4033. doi:10.1016/j.ejmech.2009.04.03719482384
   PubMed Web of Science ®Google Scholar
• SharmaS, GangalS, RaufA. Convenient one-pot synthesis of novel 2-substituted benzimidazoles, tetrahydrobenzimidazoles and imidazoles and evaluation of their in vitro antibacterial and antifungal activities. Eur J Med Chem. 2009;44(4):1751–1757. doi:10.1016/j.ejmech.2008.03.02618472189
   PubMed Web of Science ®Google Scholar
• PieczonkaAM, StrzelczykA, SadowskaB, MlostońG, StączekP. Synthesis and evaluation of antimicrobial activity of hydrazones derived from 3-oxido-1H-imidazole-4-carbohydrazides. Eur J Med Chem. 2013;64:389–395. doi:10.1016/j.ejmech.2013.04.02323648974
   PubMed Web of Science ®Google Scholar
• Al-BlewiFF, AlmehmadiMA, AouadMR, et al. Design, synthesis, ADME prediction and pharmacological evaluation of novel benzimidazole-1,2,3-triazole-sulfonamide hybrids as antimicrobial and antiproliferative agents. Chem Cent J. 2018;12(1):110. doi:10.1186/s13065-018-0479-130387018
   PubMedGoogle Scholar
• DarajiDG, RajaniDP, RajaniSD, et al. Structure based design, synthesis, and biological evaluation of imidazole derivatives targeting dihydropteroate synthase enzyme. Bioorg Med Chem Lett. 2021;36:127819.33513385
   PubMed Web of Science ®Google Scholar
• HusainA, DrabuS, KumarN, AlamMM, BawaS. Synthesis and biological evaluation of di- and tri-substituted imidazoles as safer anti-inflammatory-antifungal agents. J Pharm Bioallied Sci. 2013;5(2):154–161. doi:10.4103/0975-7406.11182223833522
   PubMedGoogle Scholar
• SaccolitiF, MadiaVN, TudinoV, et al. Design, synthesis, and biological evaluation of new 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole derivatives as antiprotozoal agents. J Med Chem. 2019;62(3):1330–1347. doi:10.1021/acs.jmedchem.8b0146430615444
   PubMed Web of Science ®Google Scholar
• RamuD, JainR, KumarRR, et al. Design and synthesis of imidazolidinone derivatives as potent anti-leishmanial agents by bioisosterism. Arch Pharm. 2019;352(4):e1800290. doi:10.1002/ardp.201800290
   Web of Science ®Google Scholar
• AguirreG, BoianiM, CerecettoH, et al. Novel antiprotozoal products: imidazole and benzimidazole N-Oxide derivatives and related compounds. Arch Pharm. 2004;337(5):259–270. doi:10.1002/ardp.200300840
   Web of Science ®Google Scholar
• AdeyemiOS, EseolaAO, PlassW, et al. Imidazole derivatives as antiparasitic agents and use of molecular modeling to investigate the structure–activity relationship. Parasitol Res. 2020;119(6):1925–1941.32279093
   PubMed Web of Science ®Google Scholar
• ChenL, DengH, CuiH, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204–7218. doi:10.18632/oncotarget.2320829467962
   PubMedGoogle Scholar
• SilvaVG, SilvaRO, DamascenoSRB, et al. Anti-inflammatory and antinociceptive activity of epiisopiloturine, an imidazole alkaloid isolated from Pilocarpus microphyllus. J Nat Prod. 2013;76(6):1071–1077. doi:10.1021/np400099m23734744
   PubMed Web of Science ®Google Scholar
• YoussefJ, NovosadSA, WinthropKL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157–x. doi:10.1016/j.rdc.2015.08.00426611557
   PubMed Web of Science ®Google Scholar
• SostresC, GargalloCJ, ArroyoMT, LanasA. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24(2):121–132. doi:10.1016/j.bpg.2009.11.00520227026
   PubMed Web of Science ®Google Scholar
• AcharKC, HosamaniKM, SeetharamareddyHR. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. Eur J Med Chem. 2010;45(5):2048–2054. doi:10.1016/j.ejmech.2010.01.02920133024
   PubMed Web of Science ®Google Scholar
• ShankarB, JalapathiP, ValeruA, Kishor KumarA, SaikrishnaB, KudleK. Synthesis and biological evaluation of new 2-(6-alkyl-pyrazin-2-yl)-1H-benz[d]imidazoles as potent anti-inflammatory and antioxidant agents. Med Chem Res. 2017;26(9):1835–1846. doi:10.1007/s00044-017-1897-7
   Web of Science ®Google Scholar
• ShantharamC. Synthesis and SAR studies of potent antioxidant and anti-inflammatory activities of imidazole Derived Schiff base analogues. Biochem Anal Biochem. 2017;06:314.
   Google Scholar
• KatikireddyR, KakkerlaR, KrishnaMPSM, DurgaiahG, ReddyYN, SatyanarayanaM. Synthesis and biological evaluation of (E)-N’-benzylidene-7-methyl-2-propyl-1H-benzo[d] imidazole-5-carbohydrazides as antioxidant, anti-inflammatory and analgesic agents. Heterocycl Comm. 2019;25(1):27–38. doi:10.1515/hc-2019-0009
   Web of Science ®Google Scholar
• RochaTM, MachadoNJ, de SousaJAC, et al. Imidazole alkaloids inhibit the pro-inflammatory mechanisms of human neutrophil and exhibit anti-inflammatory properties in vivo. J Pharm Pharmacol. 2019;71(5):849–859. doi:10.1111/jphp.1306830652314
   PubMed Web of Science ®Google Scholar
• NascimentoM, MunhozACM, TheindlLC, et al. A novel tetrasubstituted imidazole as a prototype for the development of anti-inflammatory drugs. Inflammation. 2018;41(4):1334–1348. doi:10.1007/s10753-018-0782-y29656318
   PubMed Web of Science ®Google Scholar
• BukhariSN, LauroG, JantanI, et al. Anti-inflammatory trends of new benzimidazole derivatives. Future Med Chem. 2016;8(16):1953–1967. doi:10.4155/fmc-2016-006227654499
   PubMed Web of Science ®Google Scholar
• GabaM. Design, synthesis and biological evaluation of Novel 1, 2, 5-substituted benzimidazole derivatives as gastroprotective anti-inflammatory and analgesic agents. Med Chem (Los Angeles). 2015;5(2). doi:10.4172/2161-0444.1000243
   Google Scholar
• LipinskiC, LipinskiCA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004;1:337–341. doi:10.1016/j.ddtec.2004.11.00724981612
   PubMedGoogle Scholar
• DiL, KernsEH. Drug-Like Properties: Concepts, Structure, Design and Methods: From ADME to Toxicity Optimization. Amsterdam [i pozostale]: Elsevier - Academic Press; 2019.
   Google Scholar
• SharomFJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2008;9(1):105–127. doi:10.2217/14622416.9.1.10518154452
   PubMed Web of Science ®Google Scholar
• ArnottJA, PlaneySL. The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov. 2012;7(10):863–875. doi:10.1517/17460441.2012.71436322992175
   PubMed Web of Science ®Google Scholar
• DainaA, MichielinO, ZoeteV. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717. doi:10.1038/srep4271728256516
   PubMed Web of Science ®Google Scholar
• Noriega-IribeE, Díaz-RubioL, Estolano-CobiánA, et al. In vitro and in silico screening of 2,4,5-trisubstituted imidazole derivatives as potential xanthine oxidase and acetylcholinesterase inhibitors, antioxidant, and antiproliferative agents. Appl Sci. 2020;10(8):2889. doi:10.3390/app10082889
   Google Scholar
• AbrahamMH, ChadhaHS, MitchellRC. Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci. 1994;83(9):1257–1268. doi:10.1002/jps.26008309157830242
   PubMed Web of Science ®Google Scholar
• PajouheshH, LenzGR. Medicinal chemical properties of successful central nervous system drugs. NeuroRx. 2005;2(4):541–553.16489364
   PubMedGoogle Scholar
• Cheminformatics M; 2020. Available from: https://www.molinspiration.com. Accessed 720, 2021.
   Google Scholar